DOI: 10.1055/s-00000088

TumorDiagnostik & Therapie

References

Swisher EM, Lin KK, Oza AM. et al.
Rucaparib in relapsed, platinum-sensitive high-grade ovarian carcinoma (ARIEL2 Part 1): an international, multicentre, open-label, phase 2 trial.

Lancet Oncol 2017;
18: 75-87

Download Bibliographical Data

Access:
Access: